Literature DB >> 3965850

Effects of subconvulsive and repeated electroconvulsive shock on thyrotropin-releasing hormone in rat brain.

M J Kubek, J L Meyerhoff, T G Hill, J A Norton, A Sattin.   

Abstract

Male Sprague-Dawley rats were given a single electroconvulsive shock (ECS) on alternate days and sacrificed 48 hrs after 1, 3, or 5 seizures. The content of TRH in hippocampus, pyriform cortex and amygdala was increased 2.5-fold, 5.4-fold and 4.3-fold respectively, 48 hrs. after 3 alternate-day electroconvulsive shocks (ECS) and remained unchanged after 2 additional shocks. Pyriform cortex exhibited a significant intermediate increase (1.7-fold) after only 1 ECS. In a second study, rats were sacrificed 48 hrs after a series of 5 alternate-day ECS vs. subconvulsive shocks (SCS). SCS had no significant effect in these same regions, but was seen to alter TRH in striatum. These results provide an interesting parallel to several aspects of clinical electroconvulsive treatment (ECT) of depression. Together with other findings, these data suggest also, that endogenous TRH may play a role in the modulation of convulsive seizures.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3965850     DOI: 10.1016/0024-3205(85)90116-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Some regional anatomical relationships of TRH to 5-HT in rat limbic forebrain.

Authors:  A Sattin; M J Kubek; W C Low; C J Staley; J R Simon
Journal:  Neurochem Res       Date:  1992-05       Impact factor: 3.996

Review 2.  Identification of a cortical site for stress-induced cardiovascular dysfunction.

Authors:  D F Cechetto
Journal:  Integr Physiol Behav Sci       Date:  1994 Oct-Dec

Review 3.  Attenuation of kindled seizures by intranasal delivery of neuropeptide-loaded nanoparticles.

Authors:  Michael J Kubek; Abraham J Domb; Michael C Veronesi
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

Review 4.  Neuropeptides as targets for the development of anticonvulsant drugs.

Authors:  Elke Clynen; Ann Swijsen; Marjolein Raijmakers; Govert Hoogland; Jean-Michel Rigo
Journal:  Mol Neurobiol       Date:  2014-04-06       Impact factor: 5.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.